Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Q4 2019 Haemonetics Corp Earnings Call Transcript

May 07, 2019 / 12:00PM GMT
Release Date Price: $97.99 (+4.40%)
Operator

Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal '19 Haemonetics Conference Call and Webcast. (Operator Instructions) As a reminder, this conference call may be recorded. I would now like to introduce your host for today's conference, Ms. Olga Vlasova, Investor Relations.

Olga Vlasova
Haemonetics Corporation - Senior Manager of IR

Good morning. Thank you for joining us for Haemonetics Fourth Quarter and Fiscal '19 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; and Bill burke, our CFO. Please note that all revenue growth rates that we'll refer to on this call are in constant currency unless noted otherwise. Our revenue guidance is based on organic revenue growth rate, which excludes impact from currency, product line end-of-life decisions and acquisitions and divestitures. Our remarks today will include forward-looking statements, and our actual results may differ materially from anticipated results. Information concerning factors that could cause results to differ is available in the Form 8-K we filed today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot